Science Explorer Back to mapMap

Most cited papers from Prometheus (United States)

What are the most cited papers from Prometheus (United States)?

The most cited paper from Prometheus (United States) is "Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma" (Christopher James Gibson et al., 2017), with 483 citations. Next come "Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients" (332) and "The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study" (242).

Showing 50 of 61 papers. Every paper with more than 8 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma Christopher James Gibson et al. · Journal of Clinical Oncology Open access 23 Feb 2017 483
2 Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients Keyur Patel, Stuart C. Gordon, Ira M. Jacobson et al. · Journal of Hepatology 31 Aug 2004 332
3 The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study Andres J. Yarur, Anjali Jain, Daniel Andrew Sussman et al. · Gut 10 Feb 2015 242
4 Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis Rok Seon Choung, Fred Princen, Thomas P. Stockfisch et al. · Alimentary Pharmacology & Therapeutics 27 Apr 2016 145
5 SplattingAvatar: Realistic Real-Time Human Avatars With Mesh-Embedded Gaussian Splatting Zhijing Shao, Zhaolong Wang, Zhuang Li et al. Conference paper 16 Jun 2024 136
6 Simulating price patterns for tradable green certificates to promote electricity generation from wind Andrew L. J. Ford, Klaus Vogstad, Hilary Flynn · Energy Policy 29 Nov 2005 118
7 Liquid Chromatography–Tandem Mass Spectrometry Analysis of Erythrocyte Thiopurine Nucleotides and Effect of Thiopurine Methyltransferase Gene Variants on These Metabolites in Patients Receiving Azathioprine/6-Mercaptopurine Therapy Thierry Dervieux, G. P. Meyer, Robert Barham et al. · Clinical Chemistry 16 Sep 2005 113
8 HPLC Determination of Erythrocyte Methotrexate Polyglutamates after Low-Dose Methotrexate Therapy in Patients with Rheumatoid Arthritis Thierry Dervieux, Diana Orentas Lein, John F. Marcelletti et al. · Clinical Chemistry Oct 2003 109
9 Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma Ajjai Shivaram Alva et al. · Cancer Immunology Immunotherapy Open access 6 Oct 2016 105
10 Statistical screening of system dynamics models Andrew L. J. Ford, Hilary Flynn · System Dynamics Review Dec 2005 102
11 A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease Barrett G. Levesque, Gordon R. Greenberg, Guangyong Zou et al. · Alimentary Pharmacology & Therapeutics Open access Apr 2014 101
12 Use of serum biomarkers in a diagnostic test for irritable bowel syndrome Anthony J Lembo, Bruce P Neri, Jim Tolley et al. · Alimentary Pharmacology & Therapeutics Open access 18 Feb 2009 95
13 Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma Diwakar Davar, Hong Wang, Joë-Marc Chauvin et al. · Journal of Clinical Oncology Open access 25 Oct 2018 85
14 Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease Ryan C. Ungaro, Andres J. Yarur, Jacqueline Jossen et al. · Journal of Crohn s and Colitis Open access 13 Feb 2019 64
15 Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea‐predominant IBS Filippo Cremonini, Jean Paul Nicandro, Victoria G. Atkinson et al. · Alimentary Pharmacology & Therapeutics Open access 10 Jul 2012 64
16 A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program Kenneth Tong, Jean Paul Nicandro, Reshma Shringarpure et al. · Therapeutic Advances in Gastroenterology Open access 18 Jun 2013 60
17 Correlation of FIBROSpect II With Histologic and Morphometric Evaluation of Liver Fibrosis in Chronic Hepatitis C Keyur Patel, David R. Nelson, Don C. Rockey et al. · Clinical Gastroenterology and Hepatology 11 Jan 2008 58
18 Engineering 3D parallelized microfluidic droplet generators with equal flow profiles by computational fluid dynamics and stereolithographic printing Tom Kamperman, Liliana Moreira Teixeira, Seyedeh Sarah Salehi et al. · Lab on a Chip Open access 16 Dec 2019 49
19 Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry Mayer Fishman, Janice P. Dutcher, Joseph I. Clark et al. · Journal for ImmunoTherapy of Cancer Open access 27 Mar 2019 47
20 Fostering Collaboration Through Creation of an IBD Learning Health System Lisa C. Johnson, GIL Y. MELMED, Eugene C. Nelson et al. · The American Journal of Gastroenterology 14 Feb 2017 47
21 Financial hardship in families of children or adolescents with cancer: a systematic literature review Julie Ritter, Savannah Allen, Phillip D. Cohen et al. · The Lancet Oncology ReviewOpen access 29 Aug 2023 45
22 A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma Elizabeth Iannotti Buchbinder, Anasuya Gunturi, Jessica C. Perritt et al. · Journal for ImmunoTherapy of Cancer Open access 11 Aug 2016 44
23 Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients Carol Christensen, Dana J. T. Bruden, S. Livingston et al. · Journal of Viral Hepatitis 26 Jul 2006 43
24 DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENE Hugo R. Rosen, Jennifer J Lentz, Steven L. Rose et al. · Transplantation Dec 1999 40
25 Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry Brendan D. Curti, Gregory A. Daniels, David F. McDermott et al. · Journal for ImmunoTherapy of Cancer Open access Dec 2017 39
26 Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis Joseph D. Feuerstein · Annals of Gastroenterology ReviewOpen access 2016 39
27 PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells Anna-Maria Jegg, Toby M. Ward, Elizabeth J. Iorns et al. · Breast Cancer Research and Treatment 21 Oct 2012 39
28 IEEE 802.11bf WLAN Sensing Procedure: Enabling the Widespread Adoption of WiFi Sensing Tanguy Ropitault, Claudio R. C. M. da Silva, Steve Blandino et al. · IEEE Communications Standards Magazine Mar 2024 37
29 Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM Joseph I. Clark et al. · Clinical Genitourinary Cancer Open access 29 Oct 2016 35
30 Functional N-Representability in 2-Matrix, 1-Matrix, and Density Functional Theories Eduardo V. Ludeña, Fernando Javier Torres, César Edil da Costa · Journal of Modern Physics Open access 2013 35
31 Hypocholestérolémie au cours de la phase aiguë de la réaction inflammatoire d'origine infectieuse. À propos de 120 cas Martin Bentz, J Magnette · La Revue de Médecine Interne Mar 1998 34
32 Robust scalable synthesis of a bis-urea derivative forming thixotropic and cytocompatible supramolecular hydrogels Laurens A. J. Rutgeerts, Al Halifa Soultan, Ramesh Subramani et al. · Chemical Communications Open access 2019 29
33 Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement Apostolia Maria Tsimberidou, Laura A. Levit, Richard L. Schilsky et al. · Journal of Clinical Oncology Open access 19 Oct 2018 29
34 IEEE 802.11bf DMG Sensing: Enabling High-Resolution mmWave Wi-Fi Sensing Steve Blandino, Tanguy Ropitault, Claudio R. C. M. da Silva et al. · IEEE Open Journal of Vehicular Technology Open access 2023 22
35 The Threat and Response to Infectious Diseases (Revised) Jennifer L. Brower · Microbial Ecology Open access Aug 2016 22
36 Prometheus Payment Model: Application to Hip and Knee Replacement Surgery Amita Rastogi, Beth A. Mohr, Jeffery O. Williams et al. · Clinical Orthopaedics and Related Research Open access 29 Jul 2009 21
37 Effective Platinum-Copper Catalysts for Methanol Oxidation and Oxygen Reduction in PEM FC Владислав Сергеевич Меньщиков, Anastasia A. Alekseenko, В. Е. Гутерман et al. · Preprints.org PreprintOpen access 24 Feb 2020 20
38 O-RAN with Machine Learning in ns-3 Wesley Garey, Tanguy Ropitault, Richard Rouil et al. Conference paperOpen access 19 Jun 2023 18
39 Efficient Pt-based nanostructured electrocatalysts for fuel cells: One-pot preparation, gradient structure, effect of alloying, electrochemical performance Angelina S. Pavlets, Anastasia A. Alekseenko, Ekaterina Kozhokar et al. · International Journal of Hydrogen Energy 25 Jan 2023 18
40 Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically Emily Kate Wright, María Chaparro, Paolo Gionchetti et al. · Journal of Crohn s and Colitis Open access 18 Aug 2023 17
41 Studying Legal Consciousness: Building Institutional Theory from Micro Data Susan S. Silbey · Droit et société Open access 30 Nov 2018 17
42 Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome Kevin W. Olden, William D. Chey, Reshma Shringarpure et al. · Current Medical Research and Opinion 8 Oct 2018 17
43 Null steering employing polynomials and restricted coefficients J. S. Byrnes, Donald J. Newman · IEEE Transactions on Antennas and Propagation 1988 17
44 The strangest song: One father’s quest to help his daughter find her voice Christopher L. Karp · Journal of Clinical Investigation Open access May 2007 15
45 Towards 5G new radio sidelink communications: A versatile link-level simulator and performance evaluation Peng Liu, Chen Shen, Chunmei Liu et al. · Computer Communications Open access 8 Jun 2023 14
46 Tools, Models and Dataset for IEEE 802.11ay CSI-based Sensing Steve Blandino, Tanguy Ropitault, Anirudha Sahoo et al. · 2022 IEEE Wireless Communications and Networking Conference (WCNC) Conference paper 10 Apr 2022 14
47 Inflammatory Cytokine Profile in Crohn’s Disease Nonresponders to Optimal Antitumor Necrosis Factor Therapy Andres J. Yarur, Anjali Jain, María Alejandra Quintero et al. · Journal of Clinical Gastroenterology Open access 6 Mar 2018 13
48 Measurement-Based Prediction of mmWave Channel Parameters Using Deep Learning and Point Cloud Hang Mi, Bo Ai, Ruisi He et al. · IEEE Open Journal of Vehicular Technology Open access 2024 12
49 Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy. Lennox J. Jeffers, Rafael A. Cortes, P.A. Bejarano et al. · PubMed Open access May 2007 12
50 Optical sensor for BTEX detection: Integrating machine learning for enhanced sensing Mary Hashemitaheri, Ebrahim Ebrahimi, Geethanga de Silva et al. · Advanced Sensor and Energy Materials Open access 20 Jun 2024 11

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.